As of 2025-05-17, the EV/EBITDA ratio of Aridis Pharmaceuticals Inc (ARDS) is 0.03. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ARDS's latest enterprise value is -0.03 mil USD. ARDS's TTM EBITDA according to its financial statements is -1.01 mil USD. Dividing these 2 quantities gives us the above ARDS EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.0x - 13.4x | 13.3x |
| Forward P/E multiples | 16.6x - 30.6x | 19.0x |
| Fair Price | (1,161.26) - (937.80) | (1,132.45) |
| Upside | -374580.6% - -302518.7% | -365289.6% |
| Date | EV/EBITDA |
| 2025-05-01 | 0.03 |
| 2025-04-29 | 0.03 |
| 2025-04-28 | 0.03 |
| 2025-04-25 | 0.03 |
| 2025-04-24 | 0.03 |
| 2025-04-23 | 0.03 |
| 2025-04-22 | 0.03 |
| 2025-04-21 | 0.03 |
| 2025-04-17 | 0.03 |
| 2025-04-15 | 0.03 |
| 2025-04-11 | 0.03 |
| 2025-04-10 | 0.03 |
| 2025-04-09 | 0.03 |
| 2025-04-01 | 0.03 |
| 2025-03-31 | 0.03 |
| 2025-03-28 | 0.03 |
| 2025-03-27 | 0.03 |
| 2025-03-26 | 0.03 |
| 2025-03-24 | 0.03 |
| 2025-03-20 | 0.03 |
| 2025-03-19 | 0.03 |
| 2025-03-18 | 0.03 |
| 2025-03-17 | 0.03 |
| 2025-03-13 | 0.03 |
| 2025-03-12 | 0.03 |
| 2025-03-11 | 0.03 |
| 2025-03-06 | 0.03 |
| 2025-02-28 | 0.03 |
| 2025-02-27 | 0.03 |
| 2025-02-26 | 0.03 |
| 2025-02-25 | 0.03 |
| 2025-02-24 | 0.03 |
| 2025-02-19 | 0.03 |
| 2025-02-18 | 0.03 |
| 2025-02-14 | 0.03 |
| 2025-02-11 | 0.03 |